Arizona State Retirement System’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,332
Closed -$831K 2177
2024
Q2
$831K Buy
20,332
+395
+2% +$16.4K 0.01% 1133
2024
Q1
$843K Buy
19,937
+121
+0.6% +$5.08K 0.01% 1136
2023
Q4
$840K Buy
19,816
+1,954
+11% +$56.1K 0.01% 1146
2023
Q3
$390K Buy
17,862
+261
+1% +$6.53K ﹤0.01% 1519
2023
Q2
$560K Sell
17,601
-517
-3% -$15.9K ﹤0.01% 1345
2023
Q1
$442K Buy
18,118
+539
+3% +$15.8K ﹤0.01% 1482
2022
Q4
$554K Buy
17,579
+1,460
+9% +$41.2K 0.01% 1308
2022
Q3
$456K Buy
16,119
+159
+1% +$4.74K ﹤0.01% 1371
2022
Q2
$422K Buy
15,960
+4,020
+34% +$114K ﹤0.01% 1455
2022
Q1
$418K Buy
11,940
+243
+2% +$7.1K ﹤0.01% 1587
2021
Q4
$379K Buy
11,697
+137
+1% +$4.83K ﹤0.01% 1699
2021
Q3
$341K Buy
11,560
+2,911
+34% +$81.7K ﹤0.01% 1756
2021
Q2
$222K Buy
+8,649
New +$124K ﹤0.01% 2071

Other funds holding CERE

Arizona State Retirement System's CERE Position: Q3 2024 in Review

Arizona State Retirement System sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 20,332 shares — an estimated $831K sold.

Arizona State Retirement System first reported a position in CERE in Q2 2021 and held it in 13 quarters. The position peaked at $843K in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Arizona State Retirement System reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 20,332 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $831K.
  • Arizona State Retirement System first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • Arizona State Retirement System's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $843K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Arizona State Retirement System's 13F filing for Q3 2024, filed 12 Nov 2024.